Skip nav
Flarin Logo

Joint pain relief brand Flarin® has announced that ITV’s Media for Equity investment fund, ITV AdVentures, has agreed to invest up to GBP 5 million of advertising inventory across ITV’s channels in return for a minority equity stake in the company. Flarin® is its first consumer healthcare investment to date.

Flarin® is a unique and patent-protected anti-inflammatory painkiller. Its lipid formulation of ibuprofen has been clinically proven to be as effective as twice the dose of standard ibuprofen in patients with acute joint pain*. Flarin® is one of the fastest growing oral analgesics in the UK and offers consumers a clinically proven solution for joint and muscular pain relief. It is the only lipid formulated oral analgesic available in the UK.

ITV’s investment will enable Flarin® to build brand awareness by bringing the brand to millions of UK viewers via ITV platforms. The funding will support a step change in the volume of TV advertising and the...

Read full release

Image Channel